Rethinking Letermovir Strategy Beyond Day +100 for Late CMV Prevention After Allogeneic Hematopoietic Cell Transplantation
{{output}}
Not applicable. Copyright © 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
